Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: Are they all alike?
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The behavioral profiles of five clinically used selective serotonin reuptake inhibitors (SSRIs) citalopram, paroxetine, sertraline, fluvoxamine and fluoxetine, have been compared in animal models of antidepressant (mouse forced swim test), anxiolytic (exploration of black and white test box and foot-shock-induced ultrasonic vocalization in the rat) and antiaggressive (isolation-induced aggressive behavior in the mouse) activity. the results are discussed in relation to receptor binding data from the literature. Furthermore, affinities for the sigma 1 and sigma 2 binding sites are presented. Citalopram reversed the immobility induced by forced swimming with a potency similar to that of imipramine. Paroxetine, fluvoxamine and fluoxetine reversed swim-induced immobility less potently and with a maximum of 40-50% reversal. Citalopram produced a mixed anxiogenic-/anxiolytic-like response in rats tested in the two-compartment black and white box. Paroxetine induced an anxiogenic-like response at low doses and the other SSRIs were without major effects. Citalopram and paroxetine inhibited footshock-induced ultrasonic vocalization with high potencies. The dose-response curve was biphasic for citalopram with a maximum of 64% inhibition. Sertraline and fluvoxamine inhibited the vocalization less potently, and fluoxetine induced a weak inhibitory effect corresponding to a maximum of 32%. Sertraline, fluvoxamine and fluoxetine inhibited isolation-induced aggressive behavior, whereas citalopram and paroxetine were inactive. Both 5-HT1 and 5-HT2 receptors are involved, and there was a functional interaction between 5-HT1A and 5-HT2A or 5-HT2C receptors, as ritanserin potentiated the antiaggressive effect of 1,5-HTP as well as that of 8-OH-DPAT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FST is typically used for drug screening, but is responsive to acute administration of typical antidepressants (41); the NSFT is responsive to chronic (~3 weeks) administration of typical antidepressants, but is a model of anxiety (42,43).”
From Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation (2019) · cites this paper as [41]
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
Is the forced swimming test a suitable model for revealing antidepressant activity?
Borsini, F., & Meli, A. (1988) · Psychopharmacology · doi:10.1007/bf00176837 · Cited by 1,052
Porsolt, R. D., Bertin, A., Blavet, N., Deniel, M., & Jalfre, M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90366-2 · Cited by 575
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 6×
“However, this does not explain that some of the SSRIs are inactive as none of the SSRIs has affinity for the 5-HTIA receptor (Hyttel 1994).”
InfluentialWeber, E., Sonders, M., Quarum, M., McLean, S., Pou, S., & Keana, J. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8784 · Cited by 376
Role of the serotonergic system in the forced swimming test
Borsini, F. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00050-b · Cited by 240
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1158 · Cited by 230
Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents
Fletcher, A., Cliffe, I. A., & Dourish, C. T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90185-m · Cited by 194
De Vry, J., Benz, U., Schreiber, R., & Traber, J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90530-u · Cited by 176
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice
Sánchez, C., Arnt, J., Hyttel, J., & Moltzen, E. K. (1993) · Psychopharmacology · doi:10.1007/bf02246950 · Cited by 165
Self-citation
Research works printed but not linked: 2
- Castrogiovanni P, Di-Muro A, Maremanni I (1992) Fluoxetine reduces aggressive behavior in depressive outpatients. New Trends Exp Clin Psychiat 8:57
- Sánchez C, Arnt J and Perregaard J (1994) Lu 28-179—a selective sigma ligand with potent anxiolytic effects. Soc Neurosci Abstr 20:164.16
Cited by
Bourin, M., & Hascoët, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01274-3 · Cited by 1,427
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531
Lucki, I., Dalvi, A., & Mayorga, A. (2001) · Psychopharmacology · doi:10.1007/s002130100694 · Cited by 506
Bari, A., Theobald, D. E., Caprioli, D., Mar, A. C., Aidoo-Micah, A., Dalley, J. W., & Robbins, T. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.233 · Cited by 325
“Moreover, biphasic dose-response curves have been observed after citalopram administration in a variety of tests (Dekeyne et al, 2000; Hashimoto et al, 2009; Sanchez and Meier, 1997).”
BackgroundThe age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
“Indeed, the reliance on traditional animal models of anxiety shows little positive effects of SSRIs, and indeed anxiogenic effects are often observed (Sánchez and Meier, 1997; Borsini et al., 2002).”
BackgroundEscalated aggressive behavior: Dopamine, serotonin and GABA
de Almeida, R. M. M., Ferrari, P. F., Parmigiani, S., & Miczek, K. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.004 · Cited by 305
??-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders
Hayashi, T., & Su, T.-P. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00001 · Cited by 294
A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
Sanchez, C., Reines, E. H., & Montgomery, S. A. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000023 · Cited by 295
“However, there is published evidence from preclinical in-vitro and in-vivo pharmacology studies (e.g. Sanchez and Meier, 1997) and clinical efficacy studies (Montgomery et al., 2007; Rao, 2007; Kasper et al., 2009b; Montgomery and Moller, 2009) that would support meaningful differences among SSRIs…”
BackgroundWolf, O. T., & Kirschbaum, C. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00021-1 · Cited by 287
Sánchez, C., Bergqvist, P. B. F., Brennum, L. T., Gupta, S., Hogg, S., Larsen, A., & Wiborg, O. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1364-z · Cited by 265
Self-citationDawson, L. A., & Watson, J. M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00067.x · Cited by 262
Keeney, A., Jessop, D. S., Harbuz, M. S., Marsden, C. A., Hogg, S., & Blackburn‐Munro, R. E. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01422.x · Cited by 259
Waterborne and sediment toxicity of fluoxetine to select organisms
Brooks, B. W., Turner, P. K., Stanley, J. K., Weston, J. J., Glidewell, E. A., Foran, C. M., Slattery, M., La Point, T. W., & Huggett, D. B. (2003) · Chemosphere · doi:10.1016/s0045-6535(03)00103-6 · Cited by 258
Neural Circuit Motifs in Valence Processing
Tye, K. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.001 · Cited by 247
Burghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.029 · Cited by 246
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Dale, E., Bang-Andersen, B., & Sánchez, C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.011 · Cited by 234
Self-citationLê, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00024-x · Cited by 228
The mouse ligth-dark paradigm: A review
Hascoët, M., Bourin, M., & Nic Dhonnchadha, B. Á. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00151-2 · Cited by 228
Genetic perspectives on the serotonin transporter
Murphy, D. L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K.-P., & Uhl, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00622-0 · Cited by 213
Schramm, N. L., McDonald, M. P., & Limbird, L. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04875.2001 · Cited by 217
Antidepressant-like effects in various mice strains in the forced swimming test
David, D. J. P., Renard, C. E., Jolliet, P., Hascoët, M., & Bourin, M. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1335-4 · Cited by 183
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
Goodnick, P. J., & Goldstein, B. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003021 · Cited by 183
Antidepressant-like effects in various mice strains in the tail suspension test
Ripoll, N., David, D. J. P., Dailly, E., Hascoët, M., & Bourin, M. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00034-2 · Cited by 180
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179
Foran, C. M., Weston, J., Slattery, M., Brooks, B. W., & Huggett, D. B. (2004) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-003-3042-5 · Cited by 177
Testosterone and aggressiveness.
Giammanco, M., Tabacchi, G., Giammanco, S., Majo, D. D., & Guardia, M. L. (2005) · PubMed · Cited by 243
Ramos, A., Pereira, E., Martins, G. C., Wehrmeister, T. D., & Izídio, G. S. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.007 · Cited by 171
Stress-induced vocalisation in adult animals. A valid model of anxiety?
Sánchez, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01277-9 · Cited by 161
Self-citationGrillon, C., Levenson, J., & Pine, D. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301204 · Cited by 162
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
BackgroundAntidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling
Hines, D. J., Schmitt, L. I., Hines, R. M., Moss, S. J., & Haydon, P. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.136 · Cited by 160
Castagné, V., Porsolt, R. D., & Moser, P. C. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.018 · Cited by 168
Millan, M. J., Gobert, A., Lejeune, F., Newman-Tancredi, A., Rivet, J.-M., Auclair, A., & Peglion, J.-L. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29415-5 · Cited by 146
The lonely mouse: Verification of a separation-induced model of depression in female mice
Martin, A. L., & Brown, R. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.006 · Cited by 171
Winter, C., von Rumohr, A., Mundt, A. P., Petrus, D. S., Klein, J., Lee, T., Morgenstern, R., Kupsch, A. R., & Juckel, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.002 · Cited by 162
Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression
Takahashi, A., Quadros, I. M., de Almeida, R. M. M., & Miczek, K. A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2000-y · Cited by 137
“2001 ; Sanchez and Meier 1997 ) .”
Benoit‐Marand, M., Jaber, M., & Gonon, F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00155.x · Cited by 137
Hashimoto, K., Fujita, Y., & Iyo, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301047 · Cited by 148
An Assessment of Anxiolytic Drug Screening Tests: Hormetic Dose Responses Predominate
Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802014238 · Cited by 132
“Similarly, capacity to enhance anxiogenic behavior at low doses was reported by Sanchez and Meier (1997) with selective serotonin reuptake inhibitors (SSRI) (Figures 17 and 18) and Griebel et al. (2002a) with corticotrophin-releasing factor (CRF1) receptor antagonists (Figures 19 and 20).”
BackgroundSerotonin in fear conditioning processes
Bauer, E. P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.028 · Cited by 150
Electric foot shock stress: a useful tool in neuropsychiatric studies
Bali, A., & Jaggi, A. S. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0015 · Cited by 144
Dominant–submissive behavior as models of mania and depression
Malatyńska, E., & Knapp, R. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.014 · Cited by 139
Dekeyne, A., la Cour, C. M., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1177-9 · Cited by 135
“Similarly, it would be premature to attribute the inhibition of isolationinduced aggression by S32006 in mice to a specific modulation of agonistic behavior ( Sanchez and Meier 1997 ).”
BackgroundDissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making
Crockett, M. J., Siegel, J. Z., Kurth-Nelson, Z., Ousdal, O. T., Story, G., Frieband, C., Grosse-Rueskamp, J. M., Dayan, P., & Dolan, R. J. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.021 · Cited by 122
Behavioral and Pharmacogenetics of Aggressive Behavior
Takahashi, A., Quadros, I. M., de Almeida, R. M. M., & Miczek, K. A. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_191 · Cited by 122
The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders
MacQUEEN, G. M., Born, L., & Steiner, M. S. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00188.x · Cited by 145
Ho, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00219-0 · Cited by 117
Millan, M. J., Dekeyne, A., Papp, M., Rochelle, C. D. L., MacSweeny, C., Peglion, J.-L., & Brocco, M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29416-7 · Cited by 117
Ma, X.-C., Jiang, D., Jiang, W.-H., Wang, F., Jia, M., Wu, J., Hashimoto, K., Dang, Y.-H., & Gao, C.-G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020955 · Cited by 116
“Furthermore, serotonergic drugs, including selective serotonin reuptake inhibitors, reverse isolation-induced aggressive behavior in male mice, suggesting a role for serotonergic neurotransmission in isolationinduced aggression in male mice [49,50].”
BackgroundThe 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior
Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.022 · Cited by 114
“It has been shown to reduce immobility in the forced swim test [47] and the tail suspension test [48].”
BackgroundBrocco, M., Dekeyne, A., Veiga, S., Girardon, S., & Millan, M. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00701-8 · Cited by 124
Automated tests for measuring the effects of antidepressants in mice
Crowley, J. J., Jones, M. D., O’Leary, O. F., & Lucki, I. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.014 · Cited by 109
Rodríguez‐Landa, J. F., & Contreras, C. M. (2003) · Phytomedicine · doi:10.1078/0944-7113-00340 · Cited by 107
Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats
Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000186631.53851.71 · Cited by 104
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish
Maximino, C., & Herculano, A. M. (2010) · Zebrafish · doi:10.1089/zeb.2010.0669 · Cited by 127
Werling, L. L., Keller, A. B., Frank, J. G., & Nuwayhid, S. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.013 · Cited by 107
Burghardt, N. S., & Bauer, E. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.050 · Cited by 125
Simola, N. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13999150318113800 · Cited by 98
Nishi, A., Yamaguchi, T., Sekiguchi, K., Imamura, S., Tabuchi, M., Kanno, H., Nakai, Y., Hashimoto, K., Ikarashi, Y., & Kase, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.037 · Cited by 96
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
Umathe, S. N., Manna, S. S. S., & Jain, N. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.031 · Cited by 110
Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors
Dekeyne, A., Denorme, B., Monneyron, S., & Millan, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00268-3 · Cited by 95
Mos, J., Mollet, I., Tolboom, J. T. B. M., Waldinger, M. D., & Olivier, B. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00015-7 · Cited by 96
Lieben, C. K., van Oorsouw, K. I. M., Deutz, N. E. P., & Blokland, A. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.002 · Cited by 107
Davids, E., Zhang, K., Kula, N. S., Tarazi, F. I., & Baldessarini, R. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1097 · Cited by 98
Steinberg, R., Alonso, R., Griebel, G., Bert, L., Jung, M., Oury-Donat, F., Poncelet, M., Gueudet, C., Desvignes, C., Le Fur, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29250-8 · Cited by 89
Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective
McDevitt, R. A., & Neumaier, J. F. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.05.001 · Cited by 107
“…by experiments demonstrating anxiogenic effects of acute serotonin-specific reuptake inhibitor (SSRI) administration in humans (Mir and Taylor, 1997; Spigset, 1999) and rodents (Burghardt et al., 2007; Dekeyne et al., 2000; Griebel et al., 1994; Matto et al., 1996; Sanchez and Meier, 1997).”
BackgroundSestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation
Kato, T., Pothula, S., Liu, R.-J., Duman, C. H., Terwilliger, R., Vlasuk, G. P., Saiah, E., Hahm, S., & Duman, R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126859 · Cited by 88
Vry, J. D., Schreiber, R., Melon, C., Dalmus, M., & Jentzsch, K. R. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.004 · Cited by 88
Maulvault, A. L., Santos, L. H. M. L. M., Paula, J. R., Camacho, C., Pissarra, V., Fogaça, F. H. D. S., Barbosa, V., Alves, R., Pousão‐Ferreira, P., Barceló, ., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.04.015 · Cited by 93
Animal Models of Anxiety and Anxiolytic Drug Action
Treit, D., Engin, E., & McEown, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_17 · Cited by 89
“However, it should be noted that the effects of diazepam, as well as fluoxetine, were in some cases observed only at doses that were higher than the anxiety-reducing doses ordinarily used in humans (Bartoszyk et al. 1997; Sanchez and Meier 1997; Sanchez 2003).”
ResultFish, E. W., Faccidomo, S., Gupta, S., & Miczek, K. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058206 · Cited by 83
Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze
Silva, M. T. A., Alves, C. R., & Santarem, É. M. M. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000300014 · Cited by 74
Ghasemi, M., Montaser‐Kouhsari, L., Shafaroodi, H., Nezami, B. G., Ebrahimi, F., & Dehpour, A. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1609-1 · Cited by 73
Kehne, J. H., Coverdale, S., McCloskey, T. C., Hoffman, D. C., & Cassella, J. V. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00043-5 · Cited by 73
A, T. R. D. J., Pattij, T., Veening, J. G., Waldinger, M. D., Cools, A. R., & Olivier, B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2186-6 · Cited by 69
Tõnissaar, M., Mällo, T., Eller, M., Häidkind, R., Kõiv, K., & Harro, J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.001 · Cited by 75
Histamine N-methyltransferase regulates aggression and the sleep-wake cycle
Naganuma, F., Nakamura, T., Yoshikawa, T., Iida, T., Miura, Y., Kárpáti, A., Matsuzawa, T., Yanai, A., Mogi, A., Mochizuki, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16019-8 · Cited by 77
Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment
Salchner, P., & Singewald, N. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00329-5 · Cited by 75
Inositol reduces depressive-like behaviors in two different animal models of depression
Einat, H., Karbovski, H., Korik, J., Tsalah, D., & Belmaker, R. H. (1999) · Psychopharmacology · doi:10.1007/s002130050989 · Cited by 64
Ferguson, S. A., Cisneros, F. J., Gough, B., Hanig, J. P., & Berry, K. J. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi262 · Cited by 66
The Effect of Psychological Stress and Social Isolation on Neuroimmunoendocrine Communication
Cruces, J., Venero, C., Pereda-Pérez, I., & la Fuente, M. D. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130205822 · Cited by 76
Wöhr, M., Kehl, M., Borta, A., Schänzer, A., Schwarting, R., & Höglinger, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.043 · Cited by 60
Birkett, M. A., Shinday, N. M., Kessler, E. J., Meyer, J. S., Ritchie, S., & Rowlett, J. K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.006 · Cited by 59
“, 1994); aswell as spent in the lit chamber during the light/dark test in rodents, and increases fearful reactions in response to novel stimuli (Griebel et al., 1994; Sanchez and Meier, 1997).”
BackgroundRavinder, S., Burghardt, N. S., Brodsky, R., Bauer, E. P., & Chattarji, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.137 · Cited by 59
The effects of inositol treatment in animal models of psychiatric disorders
Einat, H., & Belmaker, R. H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00355-4 · Cited by 61
Burgdorf, J., Kroes, R. A., Zhang, X.-L., Gross, A. L., Schmidt, M., Weiss, C., Disterhoft, J. F., Burch, R. M., Stanton, P. K., & Moskal, J. R. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.039 · Cited by 59
“Antidepressants have been shown to decrease rates of the aversive rat ultrasonic vocalization [17].”
Wegener, G., Bandpey, Z., Heiberg, I. L., Mørk, A., & Rosenberg, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1341-6 · Cited by 61
dos Santos, J. M., Martinez, R. C. R., & Brandão, M. L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.019 · Cited by 58
An automated analysis of rat behavior in the forced swim test
Hédou, G., Pryce, C. R., Iorio, L. D., Heidbreder, C. A., & Feldon, J. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00575-5 · Cited by 61
Joel, D., Ben-Amir, E., Doljansky, J., & Flaisher, S. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000132925.81402.0a · Cited by 56
Sugimoto, Y., Kajiwara, Y., Hirano, K., Yamada, S., Tagawa, N., Kobayashi, Y., Hotta, Y., & Yamada, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.005 · Cited by 57
Boulay, D., Depoortère, R., Louis, C., Perrault, G., Griebel, G., & Soubrié, P. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.008 · Cited by 59
Villard, V., Meunier, J., Chevallier, N., & Maurice, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10191fp · Cited by 54
Social isolation increases morphine intake: behavioral and psychopharmacological aspects
Raz, S., & Berger, B. D. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833470bd · Cited by 53
Potential antidepressant activity of sigma ligands.
Skuza, G. (2003) · PubMed · Cited by 60
Insights into the Sigma‐1 receptor Chaperone's cellular functions: A microarray report
Tsai, S., Rothman, R. K., & Su, T. (2012) · Synapse · doi:10.1002/syn.20984 · Cited by 51
“Also, Sig-1Rs are well known to exert antidepressant like effects in vivo (Nakano et al.; Sanchez and Meier, 1997) and in vitro (Nakano et al.; Takebayashi et al., 2002; Tuerxun et al.)”
BackgroundUltrasound vocalisation by rodents does not correlate with behavioural measures of persistent pain
Wallace, V. C. J., Norbury, T. A., & Rice, A. S. C. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.10.006 · Cited by 61
Wettstein, J. G., Host, M., & Hitchcock, J. M. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00014-7 · Cited by 52
Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model
Papp, M., Nalepa, I., Antkiewicz-Michaluk, L., & Sánchez, C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00778-x · Cited by 50
Self-citationJin, Z., Chen, X., Ran, Y., Li, X., Xiong, J., Zheng, Y., Gao, N., & Li, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-08953-4 · Cited by 51
Metadata
- Authors
- Sánchez, C., & Meier, E.
- Affiliations
- Lundbeck (Denmark) (DK)
- ORCID
- Sánchez, Connie
- Venue
- Psychopharmacology
- Published
- 1997-09
- Volume
- 129
- Issue
- 3
- Pages
- 197-205
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1965879244
- Cited by
- 255
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 8 · 2014: 5 · 2013: 8 · 2012: 5
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- selective serotonin reuptake inhibitors, citalopram, paroxetine, sertraline, fluvoxamine, fluoxetine, depression, anxiety, aggression, forced swim test, isolation-induced aggression, 5-HT1 receptors, 5-HT2 receptor, antidepressant effects, anxiolytic effects
- MeSH terms
- Aggression, Animals, Anxiety, Binding, Competitive, Depression, Fluoxetine, Male, Motor Activity, Vocalization, Animal, 1-Naphthylamine, Citalopram, Fluvoxamine, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Paroxetine, Receptors, sigma, Sertraline, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.